U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Use of imidazo ›1, 2-A! pyridine-3-acetamide derivatives for the therapeutic treatment of neuropsychiatric syndromes associated with disfunction of the neural circuits of the basal ganglia

Patent 5891891 Issued on April 6, 1999. Estimated Expiration Date: Icon_subject November 18, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Method of stimulating steroidogenesis with alpidem
Patent #: 5032595
Issued on: 07/16/1991
Inventor: Krueger, et al.

Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders Patent #: 5206382
Issued on: 04/27/1993
Inventor: Costa, et al.

Inventor

Assignee

Application

No. 930644 filed on 11/18/1997

US Classes:

514/300Plural hetero atoms in the bicyclo ring system

Examiners

Primary: Spivack, Phyllis G.

Attorney, Agent or Firm

Foreign Patent References

  • 0 050 563 EP. 04/12/1982

International Classes

A61K 031/44
A61K 031/415

Foreign Application Priority Data

1996-04-07 IT

Abstract

Treatment of Parkinson's disease, parkinsonian syndromes, extrapyramidal syndromes, obsessive-compulsive disorder and syndromes, and frontal and subcortical dementias, with imidazo›1,2-a!pyridine-3-acetamide derivatives of the formula (I) ##STR1## wherein Y represents a hydrogen or halogen atom or a C1-4 alkyl group, A represents naphthyl or C6 H3 X1 X2, wherein each of X1 and X2 independently of one another is a hydrogen or halogen atom, a C1-4 alkoxy group, a C1-6 alkyl group or CF3, CH3 S-- , CH3 SO2 -- or --NO2, and each of R1 and R2 independently of one another represents either a hydrogen atom, or a straight or branched C1-5 alkyl group which is unsubstituted or substituted by one or more halogen atoms, hydroxyl, --N(C1-4 alkyl)2, carbamoyl or C1-4 alkoxy groups, or an allyl group, or a propargyl group, or a C3-6 cycloalkyl group, or a benzyl group, or a phenyl group, not both R1 and R2 being hydrogen, or --NR1 R2 represents a heterocyclic ring containing from 3 to 6 carbon atoms, or a heterocyclic ring of the formula ##STR2## wherein X is O, S, CHOR' or N--R, R' being hydrogen or benzyl and R being hydrogen, a C1-4 alkyl group, or phenyl which is unsubstituted or substituted by methoxy or a halogen atom, provided that if Y is 6-chloro, A is not 4-chlorophenyl.

Other References

  • Annals of Neurology, vol. 39, No. 3, Mar. 1996, pp. 368-377, XP002008555, K.G. Rottach et al, "Dynamic Properties of Horizontal and Vertical Eye Movements in Parkinsonian Syndromes"
  • ACTA Psychiatr. Scand., vol. 80, No. 2, Aug. 1989, pp. 137-141, XP002008556, M. Casacchia et al, "A double-blind, placebo-controlled study of alpidem, a novel anxiolytic of imidazopyridine structure. . . "
  • Database Embase, Elsevier Science Publishers, Amsterdam, NL, Accession No. 92058496, 1992, Abou-Gharbia et al, XP002008559, "IV Congress of the ECNP"; Drug News Perspect., vol. 4, No. 10, 1991, pp. 647-650
  • Am. Pharm., vol. 34, No. 3, Mar. 1994, pp. 24-59, XP002008557, D.A. Hussar, "New Drugs of 1993"
  • Sem. Hop., vol. 67, No. 42-43, 1991, pp. 1905-1908, XP002008558, D. Ginestet et al, "Anxiete et insomnie: Quelles alternatives medicamenteuses aux benzodiazepines?
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$16.95more info
 
Sign InRegister
Username  
Password   
forgot password?